Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 10, keine Gesamtzahl für „study“
Suchtreffer
Begriffe & Kennungen
Blincyto · 4.8 · Study MT103-205 was a dose escalation/evaluation study in paediatric patients with relapsed or refractory B-ce
Eintrag öffnenBonviva · 4.5 · H2 blockers or proton pump inhibitors Of over 1500 patients enrolled in study BM 16549 comparing monthly with
Eintrag öffnenBonviva · 4.8 · In a two-year study in postmenopausal women with osteoporosis (BM 16549) the overall safety of Bonviva 150 mg
Eintrag öffnenBonviva · 4.8 · In the pivotal two-year study in postmenopausal women with osteoporosis (BM16550), the overall safety of intra
Eintrag öffnenBortezomib Accord · 4.5 · 12 In a drug-drug interaction study assessing the effect of omeprazole, a potent CYP2C19 inhibitor, on the pha
Eintrag öffnenBortezomib Accord · 4.5 · 45 In a drug-drug interaction study assessing the effect of omeprazole, a potent CYP2C19 inhibitor, on the pha
Eintrag öffnenBortezomib Accord · 4.5 · A drug-drug interaction study assessing the effect of ketoconazole, a potent CYP3A4 inhibitor, on the pharmaco
Eintrag öffnenBortezomib Accord · 4.5 · A drug-drug interaction study assessing the effect of ketoconazole, a potent CYP3A4 inhibitor, on the pharmaco
Eintrag öffnenBortezomib Accord · 4.5 · A drug-drug interaction study assessing the effect of melphalan-prednisone on the pharmacokinetics of bortezom
Eintrag öffnenBortezomib Accord · 4.5 · A drug-drug interaction study assessing the effect of melphalan-prednisone on the pharmacokinetics of bortezom
Eintrag öffnenBortezomib Accord · 4.5 · A drug-drug interaction study assessing the effect of rifampicin, a potent CYP3A4 inducer, on the pharmacokine
Eintrag öffnenBortezomib Accord · 4.5 · A drug-drug interaction study assessing the effect of rifampicin, a potent CYP3A4 inducer, on the pharmacokine
Eintrag öffnenBortezomib Accord · 4.5 · In the same drug-drug interaction study assessing the effect of dexamethasone, a weaker CYP3A4 inducer, on the
Eintrag öffnenBortezomib Accord · 4.5 · In the same drug-drug interaction study assessing the effect of dexamethasone, a weaker CYP3A4 inducer, on the
Eintrag öffnenBortezomib Accord · 4.8 · 21 Retreatment of patients with relapsed multiple myeloma In a study in which bortezomib retreatment was admin
Eintrag öffnenBortezomib Accord · 4.8 · 54 Retreatment of patients with relapsed multiple myeloma In a study in which bortezomib retreatment was admin
Eintrag öffnenBortezomib Accord · 4.8 · Mantle cell lymphoma In study LYM-3002 in which bortezomib was administered with rituximab, cyclophosphamide,
Eintrag öffnenBortezomib Accord · 4.8 · Mantle cell lymphoma In study LYM-3002 in which bortezomib was administered with rituximab, cyclophosphamide,
Eintrag öffnenBortezomib Accord · 4.8 · Table 10: Incidence of peripheral neuropathy in study LYM-3002 by toxicity and treatment discontinuation due t
Eintrag öffnenBortezomib Accord · 4.8 · Table 10: Incidence of peripheral neuropathy in study LYM-3002 by toxicity and treatment discontinuation due t
Eintrag öffnen